Safety of 300IR 5-Grass Tablet in Grass Pollen–Allergic Children With or Without Controlled Asthma: Further Data From a Post-Marketing Observational Study
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.607
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2019
Authors
Publisher
Elsevier BV